Navigation Links
High Court Ruling Against Preemption Hurts Patients, Helps Trial Lawyers
Date:3/5/2009

DALLAS, March 5 /PRNewswire-USNewswire/ -- Yesterday's Supreme Court ruling against preemption is disastrous for patient access to necessary medicines and research for new therapies, and clearly elevates trial lawyers and local juries as the de facto authority on drug safety.

The high court has decided that federal law does not preempt state law in matters of drug safety, and consequently, a flood of frivolous liability lawsuits will cause patients to lose access to critical new medicines.

"The victors in this decision claim that eliminating preemption would make drug companies more rigorous in ensuring their drugs are safe; unfortunately, it would more likely make companies invention-averse," said Institute for Policy Innovation (IPI) resident scholar and health care expert Dr. Merrill Matthews.

Without preemption, drug makers will be more risk averse, as they grind themselves for legal battles. The result is that patients will lose access to necessary medicines and research into new cures will decline.

"This is a win-win situation for trial lawyers, and a lose-lose for patients," said Matthews. "Lawsuits are expensive, and even the threat of baseless litigation can cause pharmaceutical firms to slow down and even stop creating and developing new products.

"Plaintiff Diana Levine's story is tragic, and the physician's assistant who misused the clearly labeled drug should be, and was, held accountable. But it's hard to see how the maker of the drug could be at fault," said Matthews.

Without a strong preemption principle, average Americans who serve on local juries will be asked to overrule the government scientists and medical experts who oversee the drug-approval process.

"Trial lawyers know that jurors are ill-suited to evaluate the merits of drug warning labels, which is exactly why they're behind this effort. Without preemption we'll see a surge of frivolous lawsuits against pharmaceutical companies and other manufacturers." said Matthews.

The Institute for Policy Innovation is an independent, non-profit public policy organization based in Dallas, Texas. Dr. Merrill Matthews is available for interview by contacting Erin Humiston at (972) 874-5139, or erin@ipi.org.


'/>"/>
SOURCE Institute for Policy Innovation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Texas Supreme Court Rules Against Medicare HMOs in Hospital Reimbursement Fight
2. Claim Filed Against the Company and Nine Other Defendants in the Haifa Magistrates Court
3. First Circuit Court of Appeals Rules Against Philip Morris in Lights Class Action
4. Wyeth and Nycomed Announce Court Denial of Preliminary Injunction
5. Massachusetts State Court Hears Suit by Breastfeeding Mother on Medical Licensing Exam
6. Cristina Saralegui Joins Celebrities Including Matthew McConaughey, Courteney Cox and Mariska Hargitay to Raise Money for Breast Cancer Research
7. Filing for Reconsideration/Press Conference ACUNA v. TURKISH, Historic Informed Consent Abortion Case to the New Jersey Supreme Court
8. Rulings Send Lawsuits Against State Farm, American Family Back to Court, Hagens Berman Sobol Shapiro Announces
9. NBME Appeals Massachusetts Judges Reversal of Lower Court in Suit for Extra Break Time During Medical Licensing Exam
10. New Report Says Health Courts Bureaucracies Offer Big Financial Burdens and Loss of Patient Rights
11. ALLs Judie Brown: Supreme Court is Wrong on Contraception Ruling
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... ... a new 21st century approach to infusing high speed technology into the fabric ... exclusively dedicated to the advancement of healthcare and wellness in a yet-to-be-named, health ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... lecture to primary eye care practitioners on the latest breakthroughs in the prevention, ... Semi-Annual Continuing Education Symposium, according to eye surgeon, Jeffrey Martin, MD, FACS, Chief ...
(Date:1/17/2017)... , ... January 17, 2017 , ... SC&H Group, a ... as a Principal in its IT Advisory Services practice . Rossi is the ... as market demand for strategic IT guidance grows, and the practice continues to expand.     ...
(Date:1/17/2017)... ... January 17, 2017 , ... Lynx Technology Partners ... US security companies for consecutive years, today announced the appointment of four members ... board nomination process to a close and positions Lynx for even faster growth ...
(Date:1/16/2017)... Creek, MI (PRWEB) , ... January 17, 2017 , ... ... abuse located in Southwest Michigan, joined other volunteers and organizations in support of the ... hundreds of children and families dressed up in colorful costumes of all designs coming ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... Research and Markets has announced the addition of the "The Top ... ... and profiles the leading 200 manufacturers and distributors of molecular diagnostics products ... United States and Europe to ... Profile information for each company in The Top 200 Molecular Diagnostics ...
(Date:1/17/2017)... BELLEFONTE, Pa. , Jan. 17, 2017 /PRNewswire/ ... Medical, Inc.(AMI) announces the addition of 6 senior ... of the TubeClear® System.  These sales leaders were ... recently acquired medical device company. Repeatedly recognized for ... of exceeding customer expectations and establishing relationships with ...
(Date:1/17/2017)...  ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ... Quinn Ph.D as Vice President Corticotropin Regulatory Affairs, ... Karen Quinn is a professional with over ... Affairs, specifically with a focus on drug products ... most recently with Takeda Pharmaceuticals International as Senior ...
Breaking Medicine Technology: